Technology Overview: Engineered sialic acid substitution for optimal glycosylated biotherapeutics; a highly stable sialic acid derivative is conjugated to a glycan of choice during downstream processing in a scalable, compliant fashion
Author: admin
Project
Chronocort: Hydrocortisone formulation for CAH in adults
Product Overview: First-in-class hydrocortisone product for the lifelong treatment of adrenal disorders
Project
Infacort: modified hydrocortisone for CAH in neonates & infants
Product Overview: First-in-class paediatric hydrocortisone replacement product for neonates and infants
Project
BN-201; small molecule for Neuromyelytis Optica & progressive MS
Product Overview: First in class SGK agonist for neurodegenerative diseases
Project
Orexin 1 inhibitors for addictive disorders
Product Overview: Best in class, selective Orexin 1 inhibitors for stress-related addictive disorders
Project
Recombinant Prokaryotic Lectins (RPLs) for analysis and purification of glycoproteins
Technology Overview: Recombinant Prokaryotic Lectins (RPLs); glycoselective analytical tools for the characterisation of biological products
Project
Novel small molecule translation inhibitor series for Pt-resistant cancers
Product Overview: Novel translation inhibitors (a disruptive technology) sourced from an edible crop plant
Project
PermaLink; Antibody Drug Conjugate (ADC) conjugation platform technology
Technology Overview: Novel conjugation platform for ADCs (Antibody Drug Conjugates)
Project
Link_TSG6: link protein for inflammatory bone disorders
Product Overview: Novel link protein for treatment of bone inflammatory disorders
Project
Novel, small molecule FX11a inhibitors
Product Overview: First in class molecules for effective anti-coagulation with minimal associated risk of bleeding